Patents by Inventor Damien Habrant

Damien Habrant has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9630914
    Abstract: Multitarget inhibitors of the enzymes Fatty Acid Amide Hydrolase (FAAH), Cyclooxygenase-1 (COX-1) and/or Cyclooxygenase-2 (COX-2) having a specific carbamate moiety on the meta or ortho position of the A ring of a substituted biphenyl core and having an halogen in the ortho position of the B ring of the biphenyl core. Also concerns the therapeutical application of the multitarget inhibitors, in particular, in the prevention and treatment of cancer.
    Type: Grant
    Filed: August 1, 2013
    Date of Patent: April 25, 2017
    Assignees: Fondazione Istituto Italiano Di Tecnologia, The Regents of the University of California, Alma Mater Studiorum—Universita' Di Bologna
    Inventors: Marco De Vivo, Rita Scarpelli, Andrea Cavalli, Marco Migliore, Daniele Piomelli, Damien Habrant, Angelo Favia
  • Publication number: 20150203447
    Abstract: Multitarget inhibitors of the enzymes Fatty Acid Amide Hydrolase (FAAH), Cyclooxygenase-1 (COX-1) and/or Cyclooxygenase-2 (COX-2) having a specific carbamate moiety on the meta or ortho position of the A ring of a substituted biphenyl core and having an halogen in the ortho position of the B ring of the biphenyl core. Also concerns the therapeutical application of the multitarget inhibitors, in particular, in the prevention and treatment of cancer.
    Type: Application
    Filed: August 1, 2013
    Publication date: July 23, 2015
    Applicants: Fondazione Istituti Italiano di Tecnologia, The Regents of the University of California, Alma Mater Studiorum-Universitá di Bologna
    Inventors: Marco De Vivo, Rita Scarpelli, Andrea Cavalli, Marco Migliore, Daniele Piomelli, Damien Habrant, Angelo Favia